Followers | 583 |
Posts | 77635 |
Boards Moderated | 5 |
Alias Born | 07/12/2010 |
Wednesday, April 24, 2024 1:54:09 PM
• Arena Pharmaceuticals
• Boehringer Ingelheim
• Fabre-Kramer Pharmaceuticals
• Jazz Pharmaceutical
• Merck & Co
• Glaxo Smith Kline
• Respirerx Pharmaceuticals
• Neurocrine Biosciences
1) Arena Pharmaceuticals was bought by Pfizer
Pfizer Completes Acquisition of Arena Pharmaceuticals
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-acquisition-arena-pharmaceuticals
2)Boehringer Ingelheim
As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Headquartered in Ingelheim,
https://en.wikipedia.org/wiki/Boehringer_Ingelheim
3)Fabre-Kramer Pharmaceuticals, Inc.
Fabre-Kramer Pharmaceuticals, Inc. (“FKP” or the “Company”), was formed to identify, develop and commercialize psychotropic drugs with significant market potential.
https://fabrekramer.com/about-us/
4) Jazz Pharmaceutical
Jazz Pharmaceutical (JAZZ ) CURRENTLY TRADING AT $107.99
https://finance.yahoo.com/quote/JAZZ/
5) Merck & Co
Merck & Co (MRK) CURRENTLY TRADING AT $126.90
https://finance.yahoo.com/quote/MRK/
6) Glaxo Smith Kline
Glaxo Smith Kline (GSK) CURRENTLY TRADING AT $40.91
https://finance.yahoo.com/quote/GSK/
7) Neurocrine Biosciences
Neurocrine Biosciences CURRENTLY TRADING AT $139.08
https://finance.yahoo.com/quote/NBIX/
Al Capone's Vault http://investorshub.advfn.com/boards/board.aspx?board_id=19446
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:05:55 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:15:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 12:52:24 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM